Home > Products > CD33 & CD16
> Human Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG)
Human Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H288)
Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD33 and anti-CD16 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
There are currently no customer reviews or questions for Human Anti-CD33 x Anti-CD16 Bispecific Antibody (IgG-IgG) (BSIG-H288). Click the button below to contact us or submit your feedback about this product.